1. Home
  2. TSBX vs AIHS Comparison

TSBX vs AIHS Comparison

Compare TSBX & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • AIHS
  • Stock Information
  • Founded
  • TSBX 2015
  • AIHS 2014
  • Country
  • TSBX United States
  • AIHS China
  • Employees
  • TSBX N/A
  • AIHS N/A
  • Industry
  • TSBX
  • AIHS Finance: Consumer Services
  • Sector
  • TSBX
  • AIHS Finance
  • Exchange
  • TSBX Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • TSBX 11.2M
  • AIHS 9.5M
  • IPO Year
  • TSBX 2023
  • AIHS 2018
  • Fundamental
  • Price
  • TSBX $0.39
  • AIHS $0.88
  • Analyst Decision
  • TSBX Buy
  • AIHS
  • Analyst Count
  • TSBX 3
  • AIHS 0
  • Target Price
  • TSBX $4.75
  • AIHS N/A
  • AVG Volume (30 Days)
  • TSBX 345.8K
  • AIHS 13.9K
  • Earning Date
  • TSBX 03-20-2025
  • AIHS 02-14-2025
  • Dividend Yield
  • TSBX N/A
  • AIHS N/A
  • EPS Growth
  • TSBX N/A
  • AIHS N/A
  • EPS
  • TSBX N/A
  • AIHS N/A
  • Revenue
  • TSBX N/A
  • AIHS $5,878,700.00
  • Revenue This Year
  • TSBX N/A
  • AIHS N/A
  • Revenue Next Year
  • TSBX N/A
  • AIHS N/A
  • P/E Ratio
  • TSBX N/A
  • AIHS N/A
  • Revenue Growth
  • TSBX N/A
  • AIHS 12.21
  • 52 Week Low
  • TSBX $0.37
  • AIHS $0.70
  • 52 Week High
  • TSBX $5.75
  • AIHS $1.45
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 40.91
  • AIHS 46.48
  • Support Level
  • TSBX $0.37
  • AIHS $0.87
  • Resistance Level
  • TSBX $0.42
  • AIHS $1.03
  • Average True Range (ATR)
  • TSBX 0.04
  • AIHS 0.07
  • MACD
  • TSBX -0.00
  • AIHS -0.00
  • Stochastic Oscillator
  • TSBX 16.62
  • AIHS 6.06

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.

Share on Social Networks: